S3134Referred to Committee

Combating Counterfeit Pharmaceuticals Act of 2025

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-11-06
Introduced
1
Cosponsors
S
ⓘ
Type

Sponsor

Tom Cotton
Tom Cotton
Republican · AR · Senator
Votes with party: 76.1% (845 recorded votes)

Full profile: /officials/C001095

Source: Congress.gov · FEC

Cosponsors (1)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.

2025-11-06

Source: Congress.gov

Committee Activity

Currently in

Previously

Plain-English Summary

This bill aims to crack down on fake and substandard medications that enter the U.S. market from other countries, protecting patients from dangerous drugs that don't contain the promised ingredients or dosages. It likely involves working with international partners to strengthen supply chain security, improve tracking of medications, and increase penalties for those involved in distributing counterfeit drugs. The legislation would affect pharmaceutical companies, importers, healthcare providers, and ultimately patients who rely on safe, authentic medications.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

International Affairs
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.